Características clínicas y pronóstico de pacientes con cáncer de mama HER2 positivo avanzado, en la era antes y después de terapias anti-HER2

par SÁNCHEZ,CESAR, DOMÍNGUEZ,FRANCISCO, GALINDO,HÉCTOR, CAMUS,MAURICIO, ODDÓ,DAVID, VILLARROEL,ALEJANDRA, RAZMILIC,DRAVNA, NAVARRO,MARÍA ELENA, PÉREZ-SEPÚLVEDA,ALEJANDRA, MEDINA,LIDIA, LÓPEZ,VALESKA, ACEVEDO,FRANCISCO
Publié 2018

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer

par Salkeni MA, Rizvi W, Hein K, Higa GM
Publié 2021

Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review

par Linehan AS, Fitzpatrick OM, Morris PG
Publié 2021

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature

par Belal Firwana, Bassel Atassi, Rim Hasan, Nour Hasan, Ammar Sukari
Publié 2012

Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab

par Martins,Sandro José, Modesto Dos Santos,Vitorino, Thommen Teles,Ludmila, Alves Leite,Viviane
Publié 2012

Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma

par Kustic,Domagoj, Lovasic,Franjo, Belac-Lovasic,Ingrid, Avirovic,Manuela, Ruzic,Alen, Petretic-Majnaric,Silvana
Publié 2019

Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography

par Jingyuan Guan, Wuyun Bao, Yao Xu, Wei Yang, Mengmeng Li, Mingjun Xu, Yu Zhang, Mei Zhang
Publié 2021

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer

par Rodallec A, Sicard G, Giacometti S, Carré M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R
Publié 2018

Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo

par Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y
Publié 2018

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity

par Esteban Cruz, Vicki Sifniotis, Zeynep Sumer-Bayraktar, Mouhamad Reslan, Lorna Wilkinson-White, Stuart Cordwell, Veysel Kayser
Publié 2021

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

par Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R
Publié 2018

Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposu...

par Quagliariello V, Vecchione R, De Capua A, Lagreca E, Iaffaioli RV, Botti G, Netti PA, Maurea N
Publié 2020

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data

par Jagosky M, Tan AR
Publié 2021

Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer

par Haruka Yamaguchi, Jotaro On, Takao Morita, Takamasa Suzuki, Yasuo Okada, Junya Ono, Andreas Evdokiou
Publié 2021

A Importância do Monitoramento e da Identificação Precoce de Cardiotoxicidade do Tratamento com Trastuzumabe no Câncer de Mama: Relato de Caso

par Patricia Marques Soares Valente, Walter Claudino Pires de Souza, Eduardo Pinho Braga, Thamires Ferreira Neves, Thamires Lopes da Silva, Wolney de Andrade Martins, Selma Rodrigues de Castilho
Publié 2019

Cardiotoxicidade nas Terapias Neoadjuvante e Adjuvante do Câncer de Mama

par Livia Christina de Oliveira Pina, Flavia Axelband, Maria Fernanda Barbosa, Mario Jorge Sobreira da Silva
Publié 2019

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

par Phung HT, Thi Nguyen H, Nguyen TV, Nguyen TV, Dinh LAT, Nguyen CV
Publié 2020

Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells

par Rodríguez-Serrano F, Mut-Salud N, Cruz-Bustos T, Gomez-Samblas M, Carrasco E, Garrido JM, López-Jaramillo FJ, Santoyo-Gonzalez F, Osuna A
Publié 2016

Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy

par Michał Żuk, Weronika Gawęda, Agnieszka Majkowska-Pilip, Magdalena Osial, Marcin Wolski, Aleksander Bilewicz, Paweł Krysiński
Publié 2021

Data provision of PIK3CA gene diversity and recombinant plasmids preparation for control DNA in developing the trastuzumab predictive response diagnostic kit

par DESRIANI DESRIANI, BUGI RATNO BUDIARTO, WIRSMA ARIF HARAHAP, M. ALI WARISMAN, AUDREY VANIA CLARISSA OMPUSUNGGU, DINA ATHARIAH, FARIDA MIRNAWATI, IDA YUSSRIYANI, FUAD ALAHWANI, AHMAD RIZQI KURNIAWAN
Publié 2016